AMRS
Amyris Inc.
Nasdaq Global Select$2.42
Open: $2.71 High: $2.71 Low: $2.42 Close: $2.43
Range: 2022-05-18 - 2022-05-19
Volume:1,508,013Market: Extended-hours
Powered by Finage Stock APIDelayed data
AMRS
Amyris Inc. 5885 HOLLIS STREET, SUITE 100 https://www.amyris.com
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.- CEO: John Melo
- Employees: 980
- Sector: Basic Materials
- Industry: Chemicals
AMRS News
Latest news about the AMRS
Biotech CEO: Synthetic Biology Will Revolutionize Beauty CareIt offers several interesting benefits.
by The Motley Fool at 5/12/22, 12:00 AMView More →- Biotech CEO: We're Only Growing Stronger With AI, Robotics
They're also helping control costs.
by The Motley Fool at 5/12/22, 12:00 AMView More → - Amyris (AMRS) Q1 2022 Earnings Call Transcript
AMRS earnings call for the period ending March 31, 2022.
by The Motley Fool at 5/10/22, 12:00 AMView More → - Amyris (AMRS) Q4 2021 Earnings Call Transcript
AMRS earnings call for the period ending December 31, 2021.
by The Motley Fool at 3/1/22, 12:00 AMView More →